Dr. Butterfield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-585-6387
Education & Training
- University of Utah HealthFellowship, Neuromuscular Medicine (Neurology), 2009 - 2011
- University of Utah HealthFellowship, Child Neurology, 2006 - 2009
- University of Utah HealthResidency, Pediatrics, 2004 - 2006
- University of Illinois College of MedicineClass of 2004
Certifications & Licensure
- UT State Medical License 2005 - 2026
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) Start of enrollment: 2018 Sep 25
- Join now to see all
Publications & Presentations
PubMed
- Respiratory function and evaluation in individuals with facioscapulohumeral muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network.Katherine D Mathews, Jonathan Suhl, Kristin M Conway, Amy Moore, Joyce T Alese
Neuromuscular Disorders. 2024-11-09 - Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years.William J Evans, Marc Hellerstein, Russell J Butterfield, Edward Smith, Michela Guglieri
The Journal of Physiology. 2024-10-01 - A Five-Year Review of Newborn Screening for Spinal Muscular Atrophy in the State of Utah: Lessons Learned.Kristen N Wong, Melissa McIntyre, Sabina Cook, Kim Hart, Amelia Wilson
International Journal of Neonatal Screening. 2024-07-22
Journal Articles
- Whole-Genome Analysis for Effective Clinical Diagnosis and Gene Discovery in Early Infantile Epileptic EncephalopathyFrancis M Filloux, Russell J Butterfield, Meghan S Candee, Joshua L Bonkowsky, Nature
Press Mentions
- The Remarkable Origins of FSHD Research in AmericaNovember 16th, 2020
- Novartis $2 Million Gene Therapy for Rare Disorder Is World’s Most Expensive DrugMay 24th, 2019
- Novartis $2 Million Gene Therapy for Rare Disorder Is World's Most Expensive DrugMay 24th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: